Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-054420
Filing Date
2023-05-01
Accepted
2023-05-01 16:32:38
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2314185d1_10ka.htm   iXBRL 10-K/A 401676
2 EXHIBIT 10.34 tm2314185d1_ex10-34.htm EX-10.34 35962
3 EXHIBIT 31.3 tm2314185d1_ex31-3.htm EX-31.3 3830
4 EXHIBIT 31.4 tm2314185d1_ex31-4.htm EX-31.4 3692
  Complete submission text file 0001104659-23-054420.txt   715419

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eyen-20221231.xsd EX-101.SCH 3042
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20221231_lab.xml EX-101.LAB 35941
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20221231_pre.xml EX-101.PRE 23624
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2314185d1_10ka_htm.xml XML 5608
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38365 | Film No.: 23874254
SIC: 2834 Pharmaceutical Preparations